Skip to content
Review

Salvage R0 Resection on Post-Recurrence Survival After Pulmonary Metastasectomy for Colorectal Cancer: A Multicenter Retrospective Study.

Sep 2026 · Annals of Surgical Oncology · 0 citations · 21 references
Medicine

TL;DR

Achieving salvage R0 resection provides a significant survival benefit comparable to repeat hepatectomy outcomes, and aggressive local intervention aimed at R0 resection should be considered a key therapeutic strategy.

View source

Similar papers

Open access Oct 2026

Conditional Recurrence-Free Survival After Hepatectomy for Colorectal Liver Metastases: Time-Dependent Prognostic Relevance of Liver Metastasis Number.

BACKGROUND AND OBJECTIVES Recurrence risk after hepatectomy for colorectal liver metastases (CRLMs) changes during follow-up, but whether baseline tumor burden remains prognostically relevant with increasing recurrence-free time is unclear. We evaluated the time-dependent prognostic relevance of liver metastasis number...

Taiki Mori, N. Sakai, T. Takayashiki et al. · 0 citations
Open access Oct 2026

Recurrence After Resection of Colorectal Liver Metastases and Its Impact on Survival: A Multistate Model-Based, Multi-institutional Observational Cohort Study.

BACKGROUND Conventional survival analyses cannot fully account for recurrence as an intermediate event that dynamically influences subsequent mortality. Multistate models (MSMs) enable explicit modeling of transitions between clinically relevant disease states; however, their application among patients undergoing resec...

Andrea Baldo, Miho Akabane, C. Charalampous et al. · 0 citations
Open access Sep 2026

Re-resection at first recurrence is associated with prolonged survival in young patients with high-grade glioma: A multi-center study

Therapeutic re-resection at first recurrence was associated with improved post-recurrence survival, which remained significant after multivariable adjustment or propensity score matching, which remained significant after multivariable adjustment or propensity score matching.

David A. Giles, Jing Wang, Markus Anzaldua-Campos et al. · 0 citations
Sep 2026

Not all early recurrences define futility: relapse patterns shape outcomes after colorectal liver metastases resection.

BACKGROUND Recurrence after curative resection of colorectal liver metastases (CRLM) is heterogeneous. Early recurrence not always implies futile surgery. This study distinguishes predictors of early recurrence versus futile surgery and examines recurrence patterns. METHODS This study analyzed the prospective LiMeT c...

R. Marino, Buonanno Silvia, Catena Marco et al. · 0 citations
Open access Oct 2026

Risk factors for recurrence after initial transurethral resection of bladder tumor in patients with non–muscle-invasive bladder cancer

Background Recurrence remains common after initial transurethral resection of bladder tumor (TURBT) for non–muscle-invasive bladder cancer (NMIBC). This study aimed to identify routinely available clinicopathological, treatment-related, and inflammatory factors associated with recurrence and to characterize recurrence-...

F. Yuan, Xiong Li, Jing Zhang et al. · 0 citations
Sep 2026

Early recurrence predicts survival in patients with 10 or more bilobar colorectal liver metastases: A LASSO regression-based nomogram model.

INTRODUCTION Parenchymal-sparing one-stage hepatectomy (POSH) has expanded surgical eligibility for patients with high-burden (≥10) colorectal liver metastases (CLM). Early recurrence (ER), defined as recurrence within 6 months, remains a challenge, and its prognostic significance and preoperative predictability in thi...

F. Milana, F. Procopio, G. Rodda et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.